Cargando…

Obesity as the common soil of non‐alcoholic fatty liver disease and diabetes: Role of adipokines

Non‐alcoholic fatty liver disease (NAFLD) describes a spectrum of liver conditions from simple steatosis, steatohepatitis to end‐stage liver disease. The prevalence of NAFLD has been on the rise in many parts of the world, including Asia, and NAFLD is now the liver disease associated with the highes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hui, Elaine, Xu, Aimin, Bo Yang, Hong, Lam, Karen S L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wiley-Blackwell 2013
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4025109/ https://www.ncbi.nlm.nih.gov/pubmed/24843689 http://dx.doi.org/10.1111/jdi.12093

Ejemplares similares

Adipokines and Non-Alcoholic Fatty Liver Disease: Multiple Interactions
por: Adolph, Timon E., et al.
Publicado: (2017)

The Correlation Between Serum Adipokines and Liver Cell Damage in Non-Alcoholic Fatty Liver Disease
por: Jamali, Raika, et al.
Publicado: (2016)

Determining the association between adipokine expression in multiple tissues and phenotypic features of non-alcoholic fatty liver disease in obesity
por: Wolfs, M G M, et al.
Publicado: (2015)

Adipokines and Endotoxemia Correlate with Hepatic Steatosis in Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Nier, Anika, et al.
Publicado: (2020)

Managing non‐alcoholic fatty liver disease in diabetes: Challenges and opportunities
por: Lee, Chi‐Ho, et al.
Publicado: (2016)

Non‐alcoholic fatty liver disease and type 2 diabetes: An update
por: Lee, Chi‐H, et al.
Publicado: (2022)

Pro-Inflammatory Adipokine and Cytokine Profiles in the Saliva of Obese Patients with Non-Alcoholic Fatty Liver Disease (NAFLD)—A Pilot Study
por: Zyśk, Beata, et al.
Publicado: (2023)

Adipokines in Non-Alcoholic Fatty Liver Disease: Are We on the Road toward New Biomarkers and Therapeutic Targets?
por: Francisco, Vera, et al.
Publicado: (2022)

Editorial: The roles and mechanisms of hepatokines, adipokines and myokines in the development of non-alcoholic fatty liver disease (NAFLD)
por: Lu, Yan
Publicado: (2022)

Association of pro-inflammatory cytokines, adipokines & oxidative stress with insulin resistance & non-alcoholic fatty liver disease
por: Kumar, Ramesh, et al.
Publicado: (2012)

The interplay between Th17 and T-regulatory responses as well as adipokines in the progression of non-alcoholic fatty liver disease
por: Świderska, Magdalena, et al.
Publicado: (2017)

Non-alcoholic fatty liver disease and diabetes
por: Hazlehurst, Jonathan M., et al.
Publicado: (2016)

Obesity, Visceral Fat, and NAFLD: Querying the Role of Adipokines in the Progression of Nonalcoholic Fatty Liver Disease
por: Mirza, M. S.
Publicado: (2011)

In search of the optimal management strategy for non‐alcoholic fatty liver disease in type 2 diabetes patients
por: Lee, Chi‐Ho, et al.
Publicado: (2020)

Linking atrial fibrillation with non-alcoholic fatty liver disease: potential common therapeutic targets
por: Ding, Ya-Hui, et al.
Publicado: (2017)

Association of Adipokines with Development and Progression of Nonalcoholic Fatty Liver Disease
por: Boutari, Chrysoula, et al.
Publicado: (2018)

Non-Alcoholic Fatty Liver Disease in Obese Youth With Insulin Resistance and Type 2 Diabetes
por: Scapaticci, Serena, et al.
Publicado: (2021)

Pediatric Fatty Liver and Obesity: Not Always Just a Matter of Non-Alcoholic Fatty Liver Disease
por: Alfani, Renata, et al.
Publicado: (2018)

Abdominal Obesity, Adipokines and Non-communicable Diseases
por: Dhawan, Deepika, et al.
Publicado: (2020)

Crosstalk between Irisin Levels, Liver Fibrogenesis and Liver Damage in Non-Obese, Non-Diabetic Individuals with Non-Alcoholic Fatty Liver Disease
por: Armandi, Angelo, et al.
Publicado: (2022)

Adipose Tissue and Adipokines: The Association with and Application of Adipokines in Obesity
por: Khan, Muhammad, et al.
Publicado: (2014)

Thyroid Function in Obese Children with Non-Alcoholic Fatty Liver Disease
por: Bilgin, Hüseyin, et al.
Publicado: (2014)

Hepcidin in morbidly obese women with non-alcoholic fatty liver disease
por: Auguet, Teresa, et al.
Publicado: (2017)

The Differential Roles of T Cells in Non-alcoholic Fatty Liver Disease and Obesity
por: Van Herck, Mikhaïl A., et al.
Publicado: (2019)

Macrophages in obesity and non-alcoholic fatty liver disease: Crosstalk with metabolism
por: Lefere, Sander, et al.
Publicado: (2019)

Obesity interacts with hyperuricemia on the severity of non-alcoholic fatty liver disease
por: Zhou, Mimi, et al.
Publicado: (2021)

Obesity indices and adipokines in non-diabetic obese patients with early stages of chronic kidney disease
por: Stępień, Mariusz, et al.
Publicado: (2013)

Cord Blood Adipokines and Lipids and Adolescent Nonalcoholic Fatty Liver Disease
por: Simpson, Joy, et al.
Publicado: (2016)

Adipokines – removing road blocks to obesity and diabetes therapy()
por: Blüher, Matthias
Publicado: (2014)

Clinical spectrum of non-alcoholic fatty liver disease in patients with diabetes mellitus
por: Chen, Kaina, et al.
Publicado: (2020)

Association of Visceral Fat Obesity, Sarcopenia, and Myosteatosis with Non-Alcoholic Fatty Liver Disease without Obesity
por: Kim, Hong-Kyu, et al.
Publicado: (2023)

Non-alcoholic fatty liver disease and diabetic retinopathy: Is there an association?
por: Jacob, Mathew, et al.
Publicado: (2023)

Fatty liver without a large “belly”: Magnified review of non-alcoholic fatty liver disease in non-obese patients
por: Yousef, Mohamad H, et al.
Publicado: (2017)

Obesity and Its Metabolic Complications: The Role of Adipokines and the Relationship between Obesity, Inflammation, Insulin Resistance, Dyslipidemia and Nonalcoholic Fatty Liver Disease
por: Jung, Un Ju, et al.
Publicado: (2014)

Non-Alcoholic Fatty Liver Disease in HIV/HBV Patients – a Metabolic Imbalance Aggravated by Antiretroviral Therapy and Perpetuated by the Hepatokine/Adipokine Axis Breakdown
por: Iacob, Simona Alexandra, et al.
Publicado: (2022)

Oxidized Lipids: Common Immunogenic Drivers of Non-Alcoholic Fatty Liver Disease and Atherosclerosis
por: Hoebinger, Constanze, et al.
Publicado: (2022)

Stigmatization is common in patients with non-alcoholic fatty liver disease and correlates with quality of life
por: Carol, Marta, et al.
Publicado: (2022)

Relationship between non-alcoholic fatty liver disease and inflammation in patients with non-alcoholic fatty liver
por: Foroughi, Mehdi, et al.
Publicado: (2016)

Genetic Polymorphisms in Non-alcoholic Fatty Liver Disease in Obese Egyptian Children
por: El-Koofy, Nehal M., et al.
Publicado: (2011)

Metabolism of cyclic GMP in non-alcoholic fatty liver disease in morbid obesity
por: Urios, Amparo, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_64qu0m0qcv11qqvhqhqpe60hnh